Drug-labels.com

Micafungin Sodium for Injection (Juno Pharmaceuticals): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
50 mg, 100 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Micafungin Sodium for Injection (Juno Pharmaceuticals)

ABOUT THIS MEDICATION

What the medication is used for:

Your doctor has prescribed Micafungin Sodium for Injection to treat one of several types of fungal infections described below.

  • Micafungin Sodium for Injection is used to treat certain fungal infections of the esophagus (food tube connecting the mouth to the stomach). These infections are called esophageal candidiasis and are caused by Candida (fungus). Healthy individuals usually have Candida in their mouth and throat without any ill effects. An infection occurs when the body’s resistance is lowered.
  • Micafungin Sodium for Injection is used to treat patients with certain fungal infections caused by Candida including Candidemia and other Candida infections as determined by the doctor.
  • Micafungin Sodium for Injection is used to help prevent fungal infections caused by Candida in patients who are undergoing a stem cell transplant.

Micafungin Sodium for Injection has not been studied for the treatment of other types of fungal infections.

What it does:

Micafungin Sodium for Injection is an antifungal drug that belongs to a class of drugs called echinocandins. Micafungin Sodium for Injection interferes with the production of a component (glucan polysaccharide) of the fungal cell wall that is necessary if the fungus is to continue living and growing. Fungal cells exposed to Micafungin Sodium for Injection have incomplete or defective cell walls, making them fragile and unable to grow.

When it should not be used:

Do not use Micafungin Sodium for Injection if you are allergic to it, another echinocandin (eg. caspofungin acetate (Cancidas) or anidulafungin (Eraxis)) or any of the ingredients in Micafungin Sodium for Injection (see What the non-medicinal ingredients are).

Use in children:

  • Micafungin Sodium for Injection should not be used in patients under 4 months of age.

What the medicinal ingredient is:

Micafungin sodium

What the non-medicinal ingredients are:

Lactose, citric acid and/or sodium hydroxide

This is a complete listing of all non-medicinal ingredients.

What dosage forms it comes in:

Micafungin Sodium for Injection (micafungin sodium) is available as a sterile powder for injection containing 50 mg micafungin (equivalent to 50.86 mg micafungin sodium) or 100 mg micafungin (equivalent to 101.73 mg micafungin sodium) per vial.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions:

  • The use of Micafungin Sodium for Injection may sometimes cause severe allergic reactions including shock (see Side Effects).
  • Serious liver problems including liver inflammation or worsening of liver failure (see Side Effects).
  • Micafungin Sodium for Injection may cause kidney problems, kidney failure, and abnormal kidney function tests.
  • Micafungin Sodium for Injection may cause destruction of red blood cells called hemolysis or hemolytic anemia.

Use in pregnancy and breast-feeding:

Micafungin Sodium for Injection has not been studied in pregnant women. Micafungin Sodium for Injection should not be used in pregnancy unless the doctor decides the potential benefit justifies the potential risk to the fetus.

It is not known if Micafungin Sodium for Injection is excreted in breast milk. You and your doctor will discuss this.

Use in patients with liver problems:

Patients with liver problems may require extra vigilance by their doctor to monitor liver function. Be sure to tell your doctor if you have had or now have liver problems.

BEFORE you use Micafungin Sodium for Injection talk to your doctor or pharmacist if:

  • You are taking or plan to take other medications, including those obtained without a prescription.
  • You have liver problems
  • You are pregnant
  • You are breast feeding
  • You are allergic to any component of Micafungin Sodium for Injection

INTERACTIONS WITH THIS MEDICATION

Micafungin Sodium for Injection and other medicines may interact with each other. Tell your healthcare professional about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Especially, tell your healthcare professional if you take:

  • sirolimus (Rapamune)
  • nifedipine (Adalat)
  • itraconazole (Sporanox)
  • amphotericin B

The doses of these medicines may need to be reduced while you are receiving Micafungin Sodium for Injection.

PROPER USE OF THIS MEDICATION

Usual dose (adults and children over 4 months of age):

The treatment schedule and dosage will be set by your doctor, who will monitor your response and condition. Micafungin Sodium for Injection should be administered once daily by slow intravenous infusion of approximately 1 hour.

Overdose:

If you think you, or a person you are caring for, have taken too much Micafungin Sodium for Injection, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctorStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
Common

Swollen veins

(phlebitis, thrombophlebitis)

✓
Liver problems (eg. yellowing of the skin and eyes, abdominal pain, nausea, vomiting and fatigue)✓
Uncommon
Serious allergic reaction and symptoms such as severe rash, itching, swelling of hands and feet, trouble breathing✓

Any medicine may have unintended or undesirable effects, so- called side effects.

Common side effects of Micafungin Sodium for Injection include rash, mental confusion, nausea, vomiting, itching, facial swelling, diarrhea, fever, fatigue and relaxing of blood vessels (vasodilation). Micafungin Sodium for Injection may also cause injection site reactions such as inflammation of the veins.

Other reported medication-related undesirable effects include: anemia, low white blood cells count, abdominal pain, injection site pain, itching, trouble breathing, swelling of the hands, ankles, or feet, impaired liver function, sleep problems, and alterations in some laboratory blood tests. Life-threatening allergic reactions have been reported rarely during administration of Micafungin Sodium for Injection.

Other side effects may also occur rarely; and, as with any prescription medication, some side effects may be serious. Ask your doctor or pharmacist for more information. Tell your doctor promptly about these or any other unusual symptoms.

This is not a complete list of side effects. For any unexpected effects while taking Micafungin Sodium for Injection contact your doctor

HOW TO STORE IT

Store between 15-30° C. Protect from light.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about Micafungin Sodium for Injection:

  • Talk to your healthcare professional.
  • Find the full Product Monograph that is prepared for healthcare professionals and includes the Consumer Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); or by contacting the sponsor, Juno Pharmaceuticals Corp. at: 1-855-819-0505.

402-2233 Argentia Road,

Mississauga, ON L5N 2X7 1-855-819-0505.

Last Revised: February 04, 2022

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02524953

Revision date stated in the text: February 4, 2022

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Micafungin Sodium for Injection (Juno Pharmaceuticals)

Rx or OTC
Prescription (Rx)?
DIN 02524953, 02524961
Schedule(s) PRESCRIPTION
Active ingredient(s) Micafungin (micafungin sodium)
Dosage form(s) Powder For Solution
Route(s) of administration Intravenous
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J02 Antimycotics for systemic use
      1. J02A Antimycotics for systemic use
        1. J02AX Other antimycotics for systemic use
          1. J02AX05 Micafungin
Company JUNO PHARMACEUTICALS CORP.
Current status Marketed
Current status date July 17, 2023
Strengths and forms
DIN Strength Dosage form(s) Current status
02524953 50 MG Powder For Solution Marketed July 17, 2023
02524961 100 MG Powder For Solution Marketed July 17, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.